Critical care illness in allogeneic hematopoietic stem-cell transplantation recipients with chronic graft versus host disease.
In critically ill Allo-HSCT recipients, the presence or severity of cGVHD is not associated with survival and should not influence the decision to admit or not the patient to the ICU. However, careful discussions about the goals of care should be undertaken in patients with severe hepatic or pulmonary involvement.